Inside the conference room.
Among the representatives present, Xie Bin was the most senior and experienced. He had a long track record of successful investments and recruiting scientists.
The representatives from the four pharmaceutical groups all submitted their respective framework partnership agreements to Wu Ting.
While Wu Ting was reviewing the four proposals, Xie Bin seized the opportunity to make his move.
"Dr. Wu, today's agreements are just general letters of intent," he began. "We can hash out the finer details after we reach a preliminary understanding."
"What I want to discuss with you are the common problems that outstanding scientists like yourself face when commercializing their research findings."
